143 related articles for article (PubMed ID: 8618397)
1. Germ cell testis cancer: 15-year review.
Kelty P; Frazier H; O'Connell K; Ghosh BC
J Surg Oncol; 1996 May; 62(1):30-3. PubMed ID: 8618397
[TBL] [Abstract][Full Text] [Related]
2. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
Cooper DE; L'esperance JO; Christman MS; Auge BK
J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
[TBL] [Abstract][Full Text] [Related]
3. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
[TBL] [Abstract][Full Text] [Related]
4. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
6. [Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].
Caty A; Depadt G; Feutry ML
Bull Cancer; 1997 Aug; 84(8):796-9. PubMed ID: 9339184
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of germ cell tumors at the threshold of the third millennium].
Géczi L; Biron P; Droz JP
Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
[TBL] [Abstract][Full Text] [Related]
8. Primary chemotherapy after orchidectomy for stage I and II nonseminoma.
Horwich A; Cullen MH; Stenning SP
Semin Oncol; 1998 Apr; 25(2):154-9. PubMed ID: 9562448
[TBL] [Abstract][Full Text] [Related]
9. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ
J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068
[TBL] [Abstract][Full Text] [Related]
10. [Current procedure for treating testicular germ-cell tumors].
Tiuliandin SA; Figurin KM; Garin AM
Urol Nefrol (Mosk); 1995; (6):40-4. PubMed ID: 8686125
[TBL] [Abstract][Full Text] [Related]
11. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
12. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
[TBL] [Abstract][Full Text] [Related]
14. Gonadal function in men with testicular cancer.
Petersen PM; Giwercman A; Skakkebaek NE; Rørth M
Semin Oncol; 1998 Apr; 25(2):224-33. PubMed ID: 9562456
[TBL] [Abstract][Full Text] [Related]
15. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
[TBL] [Abstract][Full Text] [Related]
16. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
[TBL] [Abstract][Full Text] [Related]
17. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
18. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
19. [Testicular germ cell tumors: prognosis].
Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
[TBL] [Abstract][Full Text] [Related]
20. Stage I nonseminomatous germ cell tumors: the case for management by risk stratification.
Al Ghamdi AM; Jewett MA
Can J Urol; 2005 Feb; 12 Suppl 1():62-5; discussion 103-4. PubMed ID: 15780169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
